Target Price | $15.30 |
Price | $12.54 |
Potential |
22.01%
register free of charge
|
Number of Estimates | 8 |
8 Analysts have issued a price target Adaptive Biotechnologies Corp 2026 .
The average Adaptive Biotechnologies Corp target price is $15.30.
This is
22.01%
register free of charge
$15.75
25.60%
register free of charge
$11.11
11.40%
register free of charge
|
|
A rating was issued by 13 analysts: 11 Analysts recommend Adaptive Biotechnologies Corp to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Adaptive Biotechnologies Corp stock has an average upside potential 2026 of
22.01%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 178.96 | 237.58 |
5.10% | 32.76% | |
EBITDA Margin | -81.03% | -26.05% |
26.38% | 67.85% | |
Net Margin | -89.12% | -47.43% |
32.63% | 46.78% |
9 Analysts have issued a sales forecast Adaptive Biotechnologies Corp 2025 . The average Adaptive Biotechnologies Corp sales estimate is
This results in the following potential growth metrics:
8 Analysts have issued an Adaptive Biotechnologies Corp EBITDA forecast 2025. The average Adaptive Biotechnologies Corp EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Adaptive Biotechnologies Corp Analysts have issued a net profit forecast 2025. The average Adaptive Biotechnologies Corp net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.08 | -0.74 |
30.77% | 31.48% | |
P/E | negative | |
EV/Sales | 7.77 |
9 Analysts have issued a Adaptive Biotechnologies Corp forecast for earnings per share. The average Adaptive Biotechnologies Corp EPS is
This results in the following potential growth metrics and future valuations:
Adaptive Biotechnologies Corp...
Analyst | Rating | Action | Date |
---|---|---|---|
JP Morgan |
Locked
➜
Locked
|
Locked | Aug 06 2025 |
Piper Sandler |
Locked
➜
Locked
|
Locked | Aug 06 2025 |
TD Cowen |
Locked
➜
Locked
|
Locked | Aug 06 2025 |
Craig-Hallum |
Locked
➜
Locked
|
Locked | Jun 18 2025 |
Piper Sandler |
Locked
➜
Locked
|
Locked | May 06 2025 |
Morgan Stanley |
Locked
➜
Locked
|
Locked | May 05 2025 |
Goldman Sachs |
Locked
➜
Locked
|
Locked | May 02 2025 |
Analyst Rating | Date |
---|---|
Locked
JP Morgan:
Locked
➜
Locked
|
Aug 06 2025 |
Locked
Piper Sandler:
Locked
➜
Locked
|
Aug 06 2025 |
Locked
TD Cowen:
Locked
➜
Locked
|
Aug 06 2025 |
Locked
Craig-Hallum:
Locked
➜
Locked
|
Jun 18 2025 |
Locked
Piper Sandler:
Locked
➜
Locked
|
May 06 2025 |
Locked
Morgan Stanley:
Locked
➜
Locked
|
May 05 2025 |
Locked
Goldman Sachs:
Locked
➜
Locked
|
May 02 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.